octreotate
Small moleculeexperimental
Octreotate or octreotide acid is a somatostatin analogue that is closely related to octreotide. Its amino acid sequence is — Wikipedia
Clinical trial activity
6 trials · 10 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
4
Phase 3
1
Phase 4
1
Earliest trial started Jan 1, 1995 (NCT00461149)
Timeline
Indications
Approved for
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaOctreotate ↗
Also known as
- octreotate
- octreotate
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05153772 | Phase 2 | Dec 1, 2021 | Orano, RadioMedix |
| NCT03466216 | Phase 1 | Feb 5, 2018 | Excel Diagnostics and Nuclear Oncology Center, Orano, RadioMedix |
| NCT02358356 | Phase 2 | Nov 1, 2015 | Australasian Gastro-Intestinal Trials Group, University of Sydney |
| NCT01377246 | Phase 3 | May 1, 2011 | Mario Negri Institute |
| NCT00990535 | Phase 2 | Jan 1, 2006 | University of Genoa, University of Naples Frederico II, University of Perugia, University of Udine |
| NCT00461149 | Phase 4 | Jan 1, 1995 | University of Naples Frederico II |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (10)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Orano | For profit | 2 | 0 | 2 | 2018 |
| RadioMedix | For profit | 2 | 2 | 2 | 2018 |
| University of Naples Frederico II | Academic/Hospital | 2 | 2 | 2 | 1995 |
| Australasian Gastro-Intestinal Trials Group | Academic/Hospital | 1 | 1 | 1 | 2015 |
| Excel Diagnostics and Nuclear Oncology Center | Academic/Hospital | 1 | 0 | 1 | 2018 |
| Mario Negri Institute | Academic/Hospital | 1 | 1 | 1 | 2011 |
| University of Genoa | Academic/Hospital | 1 | 0 | 1 | 2006 |
| University of Perugia | Academic/Hospital | 1 | 0 | 1 | 2006 |
| University of Sydney | Academic/Hospital | 1 | 0 | 1 | 2015 |
| University of Udine | Academic/Hospital | 1 | 0 | 1 | 2006 |
10 organizations
Page 1 / 1